FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Berberich

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Mouse

Physiology

Disorders

DNA Damage

Co-author Network

Publications

TOP 3
Rebecca Tuttle; Yongping Gao; J Nicholas Maiorano; Kelly R Miller; Paula M Termuhlen; Steven J Berberich
Novel senescence associated gene, YPEL3, is repressed by estrogen in ER+ mammary tumor cells and required for tamoxifen-induced cellular senescence.
Pooja Mandke; Benjamin Bates; Steven J Berberich; Jillian Fraser; Nicholas Wyatt; Michael P Markey
MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame.
Rebecca Tuttle; Margo Simon; David C Hitch; J Nicholas Maiorano; Minia Hellan; James Ouellette; Paula Termuhlen; Steven J Berberich
Senescence-associated gene YPEL3 is downregulated in human colon tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Berberich (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rebecca Tuttle; Yongping Gao; J Nicholas Maiorano; Kelly R Miller; Paula M Termuhlen; Steven J Berberich
Novel senescence associated gene, YPEL3, is repressed by estrogen in ER+ mammary tumor cells and required for tamoxifen-induced cellular senescence.
International journal of cancer. Journal international du cancer 2012;130(10):2291-9.
2012: Pooja Mandke; Benjamin Bates; Steven J Berberich; Jillian Fraser; Nicholas Wyatt; Michael P Markey
MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame.
PloS one 2012;7(8):e42034.
2011: Rebecca Tuttle; Margo Simon; David C Hitch; J Nicholas Maiorano; Minia Hellan; James Ouellette; Paula Termuhlen; Steven J Berberich
Senescence-associated gene YPEL3 is downregulated in human colon tumors.
Annals of surgical oncology 2011;18(6):1791-6.
2011: Kevin Kelley; Steven J Berberich
FHIT gene expression is repressed by mitogenic signaling through the PI3K/AKT/FOXO pathway.
American journal of cancer research 2011;1(1):62-70.
2011: Steven J Berberich; Amber Todd; Rebecca Tuttle
Why YPEL3 represents a novel tumor suppressor.
Frontiers in bioscience : a journal and virtual library 2011;16():1746-51.
2010: Steven J Berberich
RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signaling.
Cell cycle (Georgetown, Tex.) 2010;9(18):3640-1.
2010: Kelly R Miller; Kevin Kelley; Rebecca Tuttle; Steven J Berberich
HdmX overexpression inhibits oncogene induced cellular senescence.
Cell cycle (Georgetown, Tex.) 2010;9(16):3376-82.
2010: Kevin D Kelley; Kelly R Miller; Amber Todd; Amy R Kelley; Rebecca Tuttle; Steven J Berberich
YPEL3, a p53-regulated gene that induces cellular senescence.
Cancer research 2010;70(9):3566-75.
2009: Katherine Heminger; Michael Markey; Meldrick Mpagi; Steven J Berberich
Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.
Aging 2009;1(1):89-108.
2008: M Markey; Steven J Berberich
Full-length hdmX transcripts decrease following genotoxic stress.
Oncogene 2008;27(52):6657-66.
2007: James N McDougal; Carol M Garrett; Carol M Amato; Steven J Berberich
Effects of brief cutaneous JP-8 jet fuel exposures on time course of gene expression in the epidermis.
Toxicological sciences : an official journal of the Society of Toxicology 2007;95(2):495-510.
2006: Douglas E Paull; Katherine Heminger; Steven J Berberich
Invited commentary.
The Annals of thoracic surgery 2006;82(4):1204.
2006: Katherine Heminger; Viney Jain; Madhavi P Kadakia; B Dwarakanath; Steven J Berberich
Altered gene expression induced by ionizing radiation and glycolytic inhibitor 2-deoxy-glucose in a human glioma cell line: implications for radio sensitization.
Cancer biology & therapy 2006;5(7):815-23.
2005: Mithua Ghosh; Karen Weghorst; Steven J Berberich
MdmX inhibits ARF mediated Mdm2 sumoylation.
Cell cycle (Georgetown, Tex.) 2005;4(4):604-8.
2004: Mark Wunderlich; Mithua Ghosh; Karen Weghorst; Steven J Berberich
MdmX represses E2F1 transactivation.
Cell cycle (Georgetown, Tex.) 2004;3(4):472-8.
2003: Mithua Ghosh; Keven Huang; Steven J Berberich
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Biochemistry 2003;42(8):2291-9.
2002: Madhavi P Kadakia; Thomas Brown; Molly M McGorry; Steven J Berberich
MdmX inhibits Smad transactivation.
Oncogene 2002;21(57):8776-85.
2002: Mark Wunderlich; Steven J Berberich
Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Oncogene 2002;21(28):4414-21.
2001: Mark Jackson; Mikael Lindström; Steven J Berberich
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation.
The Journal of biological chemistry 2001;276(27):25336-41.
2001: Madhavi P Kadakia; C Slader; Steven J Berberich
Regulation of p63 function by Mdm2 and MdmX.
DNA and cell biology 2001;20(6):321-30.
2001: C C Wetzel; Steven J Berberich
p53 binds to cisplatin-damaged DNA.
Biochimica et biophysica acta 2001;1517(3):392-7.
2000: Mark Jackson; Steven J Berberich
MdmX protects p53 from Mdm2-mediated degradation.
Molecular and cellular biology 2000;20(3):1001-7.
1999: Mark Jackson; Steven J Berberich
Constitutive mdmx expression during cell growth, differentiation, and DNA damage.
DNA and cell biology 1999;18(9):693-700.
1999: Steven J Berberich; V Litteral; L D Mayo; D Tabesh; D Morris
mdm-2 gene amplification in 3T3-L1 preadipocytes.
Differentiation; research in biological diversity 1999;64(4):205-12.
1999: P E Cruz; P L Khalil; TD Dryden; HC Chiou; PS Fink; Steven J Berberich; NJ Bigley
A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D.
Vaccine 1999;17(9-10):1091-9.
1998: C C Wetzel; Steven J Berberich
DNA binding activities of p53 protein following cisplatin damage of ovarian cells.
Oncology research 1998;10(3):151-61.
1997: L D Mayo; John Turchi; Steven J Berberich
Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53.
Cancer research 1997;57(22):5013-6.
1996: L D Mayo; Steven J Berberich
Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation.
Oncogene 1996;13(11):2315-21.
1995: Steven J Berberich; Edith H Postel
PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
Oncogene 1995;10(12):2343-7.
1995: Steven J Berberich; A Trivedi; D C Daniel; Edward M Johnson; Michael Leffak
In vitro replication of plasmids containing human c-myc DNA.
Journal of molecular biology 1995;245(2):92-109.
1994: Steven J Berberich; M Cole
The mdm-2 oncogene is translocated and overexpressed in a murine plasmacytoma cell line expressing wild-type p53.
Oncogene 1994;9(5):1469-72.
1993: Steven J Berberich; Michael Leffak
DNase-sensitive chromatin structure near a chromosomal origin of bidirectional replication of the avian alpha-globin locus.
DNA and cell biology 1993;12(8):703-14.
1993: Edith H Postel; Steven J Berberich; S J Flint; C A Ferrone
Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis.
Science (New York, N.Y.) 1993;261(5120):478-80.
1992: Steven J Berberich; N Hyde-DeRuyscher; Peter J Espenshade; M Cole
max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors.
Oncogene 1992;7(4):775-9.
1992: Steven J Berberich; Michael D Cole
Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers.
Genes & development 1992;6(2):166-76.